Alector (ALEC) EV to EBITDA (2019 - 2026)
Alector's (ALEC) quarterly EV to EBITDA came in at 2.12 in Q2 2026, down 143.64% year-over-year from 4.85 in Q2 2025, and down 63.86% quarter-over-quarter from 1.29 in Q1 2026.
Analysis
Alector (ALEC) EV to EBITDA (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported EV to EBITDA for 8 consecutive years, with 2.12 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to EBITDA fell 143.64% year-over-year to 2.12 in Q2 2026; TTM through Jun 2026 was 0.41, a 133.16% decrease from a year earlier, with the FY2025 full-year figure at 0.54, down 65.53% from the prior year.
- EV to EBITDA was 2.12 for Q2 2026 at Alector, down from 1.29 in the prior quarter.
- Over five years, EV to EBITDA peaked at 35.17 in Q2 2023 and troughed at 6.79 in Q1 2022.
- A 5-year average of 3.94 and a median of 0.44 in 2024 frame the typical range for EV to EBITDA.
- The widest YoY moves for EV to EBITDA: up 1347.5% in 2025, down 4186.89% in 2025.
- Over 5 years, EV to EBITDA stood at 0.94 in 2022, then slumped by 187.12% to 2.71 in 2023, then soared by 1252.13% to 31.19 in 2024, then sank by 93.21% to 2.12 in 2025, then tumbled by 199.87% to 2.12 in 2026.
- The last three EV to EBITDA figures came in at 2.12 (Q2 2026), 1.29 (Q1 2026), and 2.12 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.12 |
| Mar 31, 2026 | -1.29 |
| Dec 31, 2025 | 2.12 |
| Sep 30, 2025 | -0.72 |
| Jun 30, 2025 | 4.85 |
| Mar 31, 2025 | 5.18 |
| Dec 31, 2024 | 31.19 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 1.35 |
| Mar 31, 2024 | -0.42 |
| Dec 31, 2023 | -2.71 |
| Sep 30, 2023 | 0.86 |
| Jun 30, 2023 | 35.17 |
| Mar 31, 2023 | 3.06 |
| Dec 31, 2022 | -0.94 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | 2.55 |
| Mar 31, 2022 | -6.79 |
| Dec 31, 2021 | -17.19 |
| Sep 30, 2021 | 8.17 |